相关实验视频
Updated: Jul 16, 2025

08:24
A Murine Model of Muscle Training by Neuromuscular Electrical Stimulation
Published on: May 9, 2012
21.1K
骨肌特异性肌酸治疗对ALS NMJ完整性和功能的影响
Agnes Badu-Mensah1,2, Xiufang Guo1, Roxana Mendez1
1NanoScience Technology Center, University of Central Florida, 12424 Research Parkway, Suite 400, Orlando, FL 32826, USA.
International journal of molecular sciences
|September 9, 2023
概括
肌酸治疗改善了骨肌肉功能和神经肌肉结合完整性在肌缩侧面硬化症 (ALS) 模型. 这表明准骨肌肉是ALS药物发现的有希望的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 骨肌肉生理学 骨肌肉生理学
- 药物发现 药物发现 药物发现
背景情况:
- 肌缩侧面硬化症 (ALS) 涉及神经肌肉结 (NMJ) 功能障碍,骨肌肉的作用在药物发现中经常被忽视.
- 临床前研究很少针对ALS治疗干预的骨肌肉.
研究的目的:
- 研究提高骨肌肉活力和功能在ALS治疗的治疗潜力.
- 确定肌酸治疗对ALS模型中NMJ完整性的影响.
主要方法:
- 使用患者衍生的诱导多能干细胞 (iPSCs) 开发表型ALS NMJ人体芯片模型.
- 在肌酸治疗后评估NMJ参数,包括数量,忠实度,稳定性和疲劳指数.
- 免疫细胞化学分析以评估后突触尼古丁性乙胆受体 (AChR) 聚类.
主要成果:
- 肌酸治疗显著提高了NMJ数量,忠实性和稳定性.
- 在用肌酸治疗的ALS NMJ模型中观察到疲劳指数降低.
- 随着肌酸补充剂的使用,人们注意到改善了后突触 AChR 集群和集群大小.
结论:
- 骨肌肉是ALS药物发现的可行治疗点.
- 考虑所有受影响组织的整体方法对于像ALS这样的多系统性疾病至关重要.
- 生物MEMs NMJ平台对突变特异性药物查有效,为罕见疾病推进个性化医疗.
相关概念视频
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Skeletal Muscle Relaxants: Adverse Effects
398
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
398
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Myasthenia Gravis: Diagnostic Tests
978
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
978
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
703
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
703
Disorders of the Skeletal Muscle
990
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
990

